Rafael Pelayo
Undefined Physician Type (Specify) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Rafael Pelayo’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G76339 · Current
Licensed to practise in California · since 1993 · expires 2026-09-30 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$47,133
Medicare paid this office $47,133 for 366 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 110 | $11,167 | $102 |
| Return visit (30+ min) | 114 | $11,149 | $90 |
| Sleep study in sleep lab (6 years or older) | 97 | $10,202 | $104 |
| Long return visit (40+ min) | 54 | $7,689 | $122 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 26 | $2,831 | $101 |
See all 7 services
| New patient visit (45+ min) | 110 | $11,167 | $102 |
| Return visit (30+ min) | 114 | $11,149 | $90 |
| Sleep study in sleep lab (6 years or older) | 97 | $10,202 | $104 |
| Long return visit (40+ min) | 54 | $7,689 | $122 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 26 | $2,831 | $101 |
| New patient visit (60+ min) | 13 | $2,102 | $162 |
| Sleep study including heart rate, breathing, and sleep time | 49 | $1,710 | $35 |
Who their Medicare patients are
366 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 11% · Women 49% · Also on Medicaid 18% · Health risk score 1.07. At or below the middle of the specialty; the typical undefined physician type clinician is at 1.67.
Conditions among them: High blood pressure 69% · Coronary heart disease 27% · Diabetes 26% · Atrial fibrillation 22% · Depression 21% · Chronic kidney disease 18% · Heart failure 14% · Cancer 13% · Stroke 8% · COPD 7% · Dementia 7%.
The office billed $344,077, Medicare allowed $63,930 and paid $47,133; for 491 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 366 | 491 | 73 | 1.07 | $344,077 | $47,133 |
| 2023 | 289 | 372 | 73 | 1.21 | $218,132 | $34,387 |
| 2022 | 216 | 283 | 72 | 1.19 | $146,049 | $27,044 |
| 2021 | 266 | 325 | 72 | 1.09 | $200,075 | $34,545 |
| 2020 | 133 | 187 | 71 | 1.09 | $124,488 | $16,303 |
| 2019 | 272 | 332 | 71 | 1.44 | $118,604 | $30,380 |
| 2018 | 302 | 360 | 71 | 1.18 | $118,797 | $32,787 |
| 2017 | 245 | 292 | 71 | 1.22 | $113,487 | $25,578 |
| 2016 | 261 | 350 | 71 | 1.10 | $137,661 | $30,308 |
| 2015 | 307 | 382 | 71 | 1.14 | $143,130 | $31,944 |
| 2014 | 281 | 349 | 71 | 1.15 | $96,824 | $25,613 |
| 2013 | 156 | 169 | 69 | 1.09 | $36,135 | $10,564 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 94 | $7,607 | $79 |
| Sleep study in sleep lab (6 years or older) | 69 | $6,959 | $101 |
| New patient visit (45+ min) | 61 | $6,755 | $111 |
| Long return visit (40+ min) | 42 | $6,567 | $122 |
| New patient visit (60+ min) | 24 | $2,889 | $120 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $1,912 | $96 |
| Sleep study including heart rate, breathing, and sleep time | 36 | $1,248 | $35 |
2022: 6 services
| Return visit (30+ min) | 69 | $5,992 | $83 |
| Long return visit (40+ min) | 42 | $5,946 | $114 |
| Sleep study in sleep lab (6 years or older) | 56 | $5,748 | $101 |
| New patient visit (45+ min) | 40 | $4,809 | $120 |
| New patient visit (60+ min) | 18 | $2,645 | $147 |
| Sleep study including heart rate, breathing, and sleep time | 29 | $895 | $31 |
2021: 6 services
| Long return visit (40+ min) | 80 | $10,342 | $119 |
| New patient visit (60+ min) | 52 | $8,681 | $167 |
| Sleep study in sleep lab (6 years or older) | 47 | $4,924 | $105 |
| Return visit (30+ min) | 55 | $4,484 | $79 |
| New patient visit (45+ min) | 31 | $3,615 | $117 |
| Sleep study including heart rate, breathing, and sleep time | 34 | $1,215 | $36 |
2020: 8 services
| Sleep study in sleep lab (6 years or older) | 33 | $3,619 | $106 |
| Long return visit (40+ min) | 28 | $3,085 | $96 |
| Extended patient service without direct patient contact, first hour | 26 | $2,694 | $104 |
| New patient visit (60+ min) | 12 | $1,552 | $129 |
| Return visit (30+ min) | 16 | $1,192 | $75 |
| New patient visit (30+ min) | 12 | $832 | $69 |
| Short return visit (20+ min) | 14 | $660 | $47 |
| Sleep study including heart rate, breathing, and sleep time | 13 | $506 | $39 |
2019: 6 services
| New patient visit (60+ min) | 61 | $8,986 | $147 |
| Return visit (30+ min) | 112 | $7,621 | $64 |
| Sleep study in sleep lab (6 years or older) | 37 | $4,191 | $107 |
| Long return visit (40+ min) | 32 | $4,023 | $96 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 31 | $3,520 | $114 |
| Sleep study including heart rate, breathing, airflow, and effort | 18 | $797 | $44 |
2018: 6 services
| New patient visit (60+ min) | 78 | $10,489 | $134 |
| Long return visit (40+ min) | 94 | $9,040 | $87 |
| Return visit (30+ min) | 82 | $5,143 | $61 |
| Sleep study in sleep lab (6 years or older) | 34 | $3,333 | $98 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 31 | $3,164 | $102 |
| Sleep study including heart rate, breathing, airflow, and effort | 16 | $800 | $50 |
2017: 6 services
| Return visit (30+ min) | 105 | $7,240 | $63 |
| New patient visit (60+ min) | 48 | $6,635 | $138 |
| Long return visit (40+ min) | 50 | $5,085 | $91 |
| Sleep study in sleep lab (6 years or older) | 37 | $3,936 | $106 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,363 | $114 |
| Sleep study including heart rate and breathing attended by technician | 12 | $670 | $56 |
2016: 7 services
| Return visit (30+ min) | 117 | $8,884 | $67 |
| Long return visit (40+ min) | 65 | $6,652 | $89 |
| New patient visit (60+ min) | 44 | $6,073 | $138 |
| Sleep study in sleep lab (6 years or older) | 49 | $5,347 | $109 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 13 | $1,483 | $114 |
| Sleep study including heart rate and breathing attended by technician | 11 | $616 | $56 |
| Short return visit | 13 | $246 | $19 |
2015: 7 services
| Return visit (30+ min) | 140 | $10,193 | $65 |
| Long return visit (40+ min) | 57 | $6,951 | $94 |
| Sleep study in sleep lab (6 years or older) | 53 | $5,501 | $104 |
| New patient visit (60+ min) | 24 | $3,491 | $145 |
| New patient visit (45+ min) | 17 | $1,905 | $112 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 14 | $1,478 | $106 |
| Short return visit | 13 | $227 | $17 |
2014: 5 services
| Return visit (30+ min) | 170 | $12,930 | $66 |
| New patient visit (45+ min) | 39 | $4,168 | $107 |
| Long return visit (40+ min) | 29 | $3,654 | $94 |
| Sleep study in sleep lab (6 years or older) | 21 | $2,196 | $105 |
| Short return visit | 31 | $669 | $21 |
2013: 3 services
| Return visit (30+ min) | 112 | $7,061 | $60 |
| New patient visit (30+ min) | 22 | $1,328 | $60 |
| Long return visit (40+ min) | 11 | $1,052 | $96 |
Medicaid work
$866 in 2024
Medicaid paid $866 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 13 | $866 |
| 2024 | 13 | 1 | 12 | $866 |
| 2022 | 13 | 1 | 13 | $921 |
| 2019 | 14 | 1 | 14 | $411 |
See the largest Medicaid services in earlier years
2022
| New patient visit (45+ min) | 13 | $921 |
2019
| Return visit (30+ min) | 14 | $411 |
Drugs they prescribed that Part D paid
$80,711
Pharmacies billed $80,711 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
23 generic and 21 brand-name prescriptions · $80,711 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 12 | $8,331 | $694 |
Year by year
| 2024 | 44 | 20 | None | 48% | $80,711 |
| 2023 | 29 | 13 | None | 48% | $54,663 |
| 2022 | 40 | None | 0% (0) | 63% | $13,464 |
| 2021 | 23 | None | 0% (0) | 61% | $9,978 |
| 2018 | 15 | None | 0% (0) | 0% | $360 |
| 2017 | 33 | 16 | 0% (0) | None | $2,621 |
| 2016 | 67 | 20 | 0% (0) | None | $3,062 |
| 2015 | 58 | 18 | 0% (0) | None | $4,273 |
| 2014 | 55 | 17 | None | 25% | $7,810 |
| 2013 | 16 | None | 0% (0) | None | $4,091 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Belsomra | 24 | $13,204 | $550 |
2021: 1 drug
| Belsomra | 13 | $9,338 | $718 |
2016: 3 drugs
| Pramipexole Dihydrochloride | 26 | $615 | $24 |
| Gabapentin | 12 | $210 | $18 |
| Zolpidem | 13 | $167 | $13 |
2015: 1 drug
| Pramipexole Dihydrochloride | 25 | $442 | $18 |
2014: 1 drug
| Pramipexole Dihydrochloride | 22 | $293 | $13 |
Money from drug and device companies
$3,628 in 2025
| 2025 | 1 | 4 | $2,750 | $3,628 |
| 2024 | 1 | 2 | None | $143 |
| 2023 | 2 | 5 | $5,775 | $6,079 |
| 2022 | 2 | 7 | $5,278 | $5,499 |
| 2021 | 1 | 1 | None | $124 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $3,628 | 4 payments
|
See all 4 published payments
| Fisher & Paykel Healthcare | Paid to speak or teach · 2025-10-31 | Fisher & Paykel Healthcare | $2,750 |
| Fisher & Paykel Healthcare | Travel · 2025-10-31 | Fisher & Paykel Healthcare | $213 |
| Fisher & Paykel Healthcare | Meals · 2025-09-28 | Fisher & Paykel Healthcare | $112 |
| Fisher & Paykel Healthcare | Travel · 2025-08-14 | Fisher & Paykel Healthcare | $553 |
See earlier years (2024, 2023, 2022, 2021)
2024: $143
| Jazz Pharmaceuticals | Xywav | $143 | 2 payments
|
2023: $6,079
| Idorsia Pharmaceuticals US | Quviviq | $5,977 | 3 payments
|
| Jazz Pharmaceuticals | Xywav | $102 | 2 payments
|
2022: $5,499
| Eisai | Dayvigo | $4,924 | 6 payments
|
| Idorsia Pharmaceuticals US | None | $575 | 1 payment
|
2021: $124
| Eisai | Dayvigo | $124 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1699822940
- Licence
- CA G76339California G76339: Current · expires 2026-09-30
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 1988
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080S0012X (2080S0012X); Federal specialty code 2084S0012X (2084S0012X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-05
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Quarry Road, Stanford, CA, 94305